IP Strategy

Brilliant innovations in MedTech can vanish into obscurity faster than you can say ‘patent pending.’ The difference between breakthrough success and crushing disappointment often comes down to one critical factor that many startups overlook until it's too late: intellectual property strategy.

Imagine. You've spent three years developing a revolutionary device. The clinical trials are promising, investors are circling, and regulatory approval appears to be within reach. But when a competitor files a patent that blocks your path to market, your innovation becomes worthless overnight. Not because it wasn't brilliant, but because you failed to build the right protective walls around it from the beginning.

The companies that thrive understand a fundamental truth, where in an industry where development cycles span decades and regulatory hurdles tower like mountains, intellectual property isn't just legal paperwork. It's your strategic moat, your competitive weapon, and often, your lifeline to your innovation’s survival.

The MedTech minefield

Medical technology exists in a unique intellectual property ecosystem. Unlike software, where speed to market can trump patents, or consumer goods, where brand recognition might be king, MedTech operates in a world where regulatory approval takes years, development costs run into millions, and a single patent can make or break an entire company.

Without freedom to practice your invention, you could be at risk of having to pay monetary damages to a patent owner, or worse, having a court bar you from making, using, or selling your product. The expense of product development and the expense and delay of regulatory approvals are too great to attract a development partner or investment capital unless the investor is comfortable that you have freedom to practice your invention.

_{Gerard von Hoffmann and Bryan Wahl, IP experts at Knobbe Martens}

The stakes couldn't be higher. Consider that the average medical device takes 3-7 years to reach market, with development costs often exceeding £10 million. During this extended journey, competitors don’t sit still. They're filing patents, building portfolios, and positioning themselves to either block your progress (or acquire your technology at a fraction of its potential value).

Provisional patents

Your first move should be filing a provisional patent application. This is about buying yourself twelve months of breathing room, while you establish your stake in the innovation landscape. The beauty of a provisional application lies in its flexibility. You can file with detailed technical specifications and still refine your invention as development progresses.

But here's where many companies stumble. They treat provisional patents as cheap placeholders rather than strategic documents. A well-crafted provisional application should read like a detailed technical manual, covering not just what you've built, but what you might build. Those extra embodiments and variations you include today could become invaluable claim material tomorrow.

Safeguards

Not everything can or should be patented. Some of your most valuable innovations might be the manufacturing processes, algorithms, or technical know-how that competitors couldn't reverse-engineer even if they tried. This is where trade secret protection becomes crucial.

Effective trade secret protection goes far beyond making employees sign non-disclosure agreements. It requires identifying what information truly provides a competitive advantage, implementing robust security protocols, and creating clear documentation trails that prove you treated the information as confidential. Once a trade secret becomes public, it's gone forever.

Design patents

In an industry obsessed with function, it's easy to dismiss design patents as superficial. However, medical devices increasingly compete on user experience, and a distinctive design can become a powerful market differentiator.
Design patents protect the ornamental appearance of your device. The curves, colours, and overall aesthetic that make users choose your product over alternatives. They're relatively inexpensive to obtain and can provide robust protection against copycat products. More importantly, they're harder for competitors to design without compromising functionality.

Brand building through trademarks

Your company name, product names, and logos make valuable intellectual property assets that can outlast your patents. While patents eventually expire, trademarks can provide perpetual protection as long as they're actively used and defended.

Smart trademark strategy goes beyond registering obvious names. So, consider protecting key technical terms, slogans, and even distinctive product features that could become synonymous with your brand. Apple's ‘iPhone’ and ‘iPad’ trademarks demonstrate just how powerful brand protection can extend far beyond traditional naming conventions.

Freedom to operate: the reality check

Perhaps the most critical element of IP strategy is conducting a thorough freedom-to-operate analysis. To understand the entire landscape of intellectual property that could impact your product.

Medtech companies need to be more strategic in the way they protect their intellectual property. Protection of digital features introduces additional considerations that do not arise when protecting more traditional medical devices. Companies need to carefully consider which digital features can be protected with patents, and which other options are available to protect their intellectual property.

_{Roman Fayerberg. Patent attorney at Greenberg Traurig}

A comprehensive FTO analysis should begin early in development and continue throughout the product lifecycle. Technologies evolve, new patents are filed, and existing patents expire. What looks like a clear path today might be blocked tomorrow. Alternatively, obstacles that seem insurmountable now might even disappear as patents expire.

The layered approach

The most sophisticated MedTech companies don't rely on any single IP protection strategy. They create layered defences that make it difficult for competitors to challenge their market position. Your idea, for instance, might be protected by utility patents covering the sensing technology, design patents protecting the ergonomic housing, trademarks for the product name and interface elements, and trade secrets surrounding the manufacturing process.

This layered approach will serve multiple strategic purposes. It would create multiple barriers that competitors would need to overcome, provide flexibility in licensing negotiations, and ensure that even if one protection fails, others remain in place. It also creates what patent strategists call ‘design-around difficulty.’ This will make it too complex and expensive for competitors to avoid your IP, so they're better off licensing or partnering with you.

Building for the long term

Intellectual property strategy in MedTech is an ongoing process that needs to evolve with your technology, market position, and business objectives. The provisional patent you file today might become the foundation for a portfolio of dozens of patents. The trade secrets you protect now might become the clinical cash cow of tomorrow.

Waypoint checklist

A considered reminder of IP & strategy to guide you and your innovation.

• Learn to file a provisional patent to lock in an early priority date with detailed tech specs.
• Protect trade secrets with safeguard unpatentable know-how with NDAs and protocols.
• Secure design patents that cover unique ergonomic and aesthetic features.
• Trademark the brand, register names, logos and build your market identity.
• Conduct FTO analysis to avoid infringement risks from competitors’ patents.
• Combine all of the above into a layered IP strategy to minimise risks.

Need help with your IP strategy?

We help innovators learn to build layered protection around their innovations. From mapping competitive landscapes to creating patent strategies that block larger competitors, our participants work through real scenarios to protect AI diagnostics with provisional patents, secure trade secrets for proprietary datasets, and use design patents to differentiate between user interfaces.

Contact us CTA?